Sumithra J. Mandrekar
Publications by Year
Research Areas
Statistical Methods in Clinical Trials, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Health Systems, Economic Evaluations, Quality of Life, Lung Cancer Research Studies
Most-Cited Works
- → iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics(2017)2,334 cited
- → Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation(2017)2,152 cited
- → RECIST 1.1—Update and clarification: From the RECIST committee(2016)1,839 cited
- → Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL(2018)938 cited
- → CT Screening for Lung Cancer: Five-year Prospective Experience(2005)638 cited
- → Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference(2020)395 cited
- → Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges(2009)392 cited
- → Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials(2011)387 cited
- → RECIST 1.1 – Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group(2016)368 cited
- → Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma(2009)320 cited